LXS logo

LANXESS Aktiengesellschaft Stock Price

XTRA:LXS Community·€1.3b Market Cap
  • 3 Narratives written by author
  • 1 Comments on narratives written by author
  • 25 Fair Values set on narratives written by author

LXS Share Price Performance

€15.30
-10.20 (-40.00%)
€17.91
Fair Value
€15.30
-10.20 (-40.00%)
14.6% undervalued intrinsic discount
€17.91
Fair Value
Price €15.30
AnalystConsensusTarget €17.91
AnalystLowTarget €12.50
AnalystHighTarget €25.68

LXS Community Narratives

·
Fair Value €17.91 14.6% undervalued intrinsic discount

Analysts Lower LANXESS Price Target and Ratings Amid Mixed Outlook and Valuation Shifts

1users have liked this narrative
1users have commented on this narrative
8users have followed this narrative
·
Fair Value €12.5 22.4% overvalued intrinsic discount

Rising Compliance Costs And Stiff Asian Competition Will Impede Recovery

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value €25.68 40.4% undervalued intrinsic discount

Sustainable Chemicals And EV Demand Will Transform Market Dynamics

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
€12.5
22.4% overvalued intrinsic discount
Profit Margin
0.17%
Future PE
133.75x
Price in 2029
€15.68
€25.68
40.4% undervalued intrinsic discount
Profit Margin
0.39%
Future PE
108.11x
Price in 2029
€32.19

Trending Discussion

No trending discussion available.

Updated Narratives

LXS logo

LXS: Future Rally Looks Vulnerable As Middle East Conflict Risks Deepen

Fair Value: €12.5 22.4% overvalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
LXS logo

LXS: Mixed Bank Downgrades Will Drive Bullish Repricing On Middle East Risk

Fair Value: €25.68 40.4% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
LXS logo

LXS: Future Earnings Multiples Will Balance Mixed Ratings And Margin Execution Risk

Fair Value: €17.91 14.6% undervalued intrinsic discount
8 users have set this as their fair value
1 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with mediocre balance sheet.

1 Risk
2 Rewards

LANXESS Aktiengesellschaft Key Details

€5.5b

Revenue

€4.4b

Cost of Revenue

€1.1b

Gross Profit

€1.7b

Other Expenses

-€661.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 07, 2026
-7.66
19.65%
-12.13%
71.7%
View Full Analysis

About LXS

Founded
1863
Employees
11630
CEO
Matthias Zachert
WebsiteView website
lanxess.com

LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the agrochemicals, pharmaceuticals, and specialty chemicals industries. It also offers additives, lubricants, flame retardants, plasticizers, and bromine derivatives for various rubber, plastic and paint, electrical/electronics, and construction industries. In addition, the company provides basic and fine chemicals, organometallics, and inorganic pigments for the coloring of construction materials, as well as paints and coatings. It serves the energy, natural resources, industrial applications, nutrition, health, consumer goods, agriculture, animal health, construction, chemicals, and mobility industries. LANXESS Aktiengesellschaft was founded in 1863 and is headquartered in Cologne, Germany.

Recent LXS News & Updates

Narrative Update Jul 17

LXS: Future Rally Looks Vulnerable As Middle East Conflict Risks Deepen

LANXESS sees its analyst derived fair value estimate move from €11.00 to €12.50, as analysts factor in modestly adjusted growth assumptions, sharply lower profit margin expectations, and a much higher future P/E multiple reflected in recent price target changes between €13 and €18. Analyst Commentary Recent commentary on LANXESS has tilted clearly cautious, with several bearish analysts revisiting both ratings and price targets.
Analysis Article Jun 20

LANXESS (XTRA:LXS) Stock Could Be 4.4% Undervalued After Bond Issue And Ownership Shifts

LANXESS (XTRA:LXS) has drawn investor attention after completing a €494.53 million senior unsecured notes offering due 2031, while recent voting rights disclosures from Stowers Institute and JPMorgan highlight shifting institutional ownership. See our latest analysis for LANXESS. At a share price of €17.12, LANXESS has seen a 7.74% 1-day share price return and a 46.95% 90-day share price return, while the 1-year total shareholder return is down 28.67%. This suggests that recent momentum has...
Narrative Update Jun 17

LXS: Mixed Bank Downgrades Will Drive Bullish Repricing On Middle East Risk

The analyst price target for LANXESS has been reduced by €0.61, as analysts factor in recent downgrades and lower price targets related to concerns about pricing, balance sheet strength and demand risks highlighted in recent research. Analyst Commentary Recent research on LANXESS reflects a cautious tone overall, but there are still some constructive elements that matter for how you think about the stock's valuation and execution risk.

Recent updates

No updates